MAPK15 and breast carcinoma: Moreover, Groehler and Lannigan [66] demonstrated ERK8, which is active in primary mammary cells but inactivated in breast cancer cell lines, interacts with Proliferating Cell Nuclear Antigen (PCNA), thereby preventing its degradation und supporting correct transfer of genetic information.